momentum continu expect remain high rais pt maintain neutral
invest summari maintain neutral rate rais pt
report revenu line factset consensu
organ growth upper end full-year guidanc ep beat
consensu organ growth led strong growth medsurg
rais lower end organ revenu growth
ep guidanc reflect continu momentum oper margin expans
remain confid deliv full-year target
despit roughli headwind recent acquisit mako
strong quarter yet seen impact recent
launch ow rosa total knee applic continu believ
investor expect remain high think may difficult
share significantli outperform
 organ growth broad-bas revenu line consensu
higher-than-expect fx headwind off-set better-than-expect organ
revenu growth organ growth led medsurg
balanc growth us ou
acquisit headwind adjust dilut ep beat consensu
better-than-expect tax rate partial off-set higher-than-
expect fx headwind om improv y/i despit
headwind recent acquisit
 continu strength mako drive knee growth syk mako continu
strong momentum y/i system sold global includ
us util y/i total knee procedur
perform total knee overal mako
procedur sequenti flat due primarili season continu
anticip strong robot sale state current see
chang mako sale cycl result rosa
 rais lower end organ revenu growth ep guidanc
rais organ revenue growth guidanc
adjust ep estim expect
ep short consensu continu
expect meet goal annual oper margin expans
 updat estim lower revenu
respect primarili due bigger fx
headwind rais ep
 valuat price target base price-to-earnings multipl
disclosur section may found page
sourc compani document factset cantor fitzgerald estim
exhibit comparison cantor estim
sourc compani document cantor fitzgerald estim
stryker corpor million except per dilut corpor million except per share current priorcurr priorp growth growth incom excl share april
price target base price-to-earnings multipl ep estim assum
trade premium median large-cap med-tech peer higher organ top-
mako total knee applic traction could stall although signific proport syk
total revenu slowdown traction temporari setback could damag investor confid
syk hip knee busi given visibl program street
hospit capit purchas cyclic syk medsurg busi sell larg piec capit
equip sale could neg affect slowdown capit spend
hospit capit spend typic depend macroeconom environ chang
regulatori requir polit pressur healthcar industri could lessen hospit
willing and/or abil invest expens capit equip
orthoped implant could come increas price pressur present syk orthoped
busi typic experi price pressur around although see anyth
specif could increas price pressur near term gener implant bundl payment
program could neg impact price time becom preval
million except per share data
sale
compani document cantor fitzgerald research
offer rang medic technolog includ orthoped medic surgic neurotechnolog spine product
compani segment includ orthopaed medsurg neurotechnolog spine corpor orthopaed segment
includ reconstruct hip knee trauma implant system relat product medsurg segment includ surgic
equip surgic navig system endoscop commun system patient handl emerg medic equip
intens care dispos product reprocess remanufactur medic devic relat product neurotechnolog
spine segment includ neurovascular product spinal implant system relat product compani product includ
implant use joint replac trauma surgeri product use rang medic specialti
